In vitro generation of osteochondral composites

被引:225
作者
Schaefer, D
Martin, I
Shastri, P
Padera, RF
Langer, R
Freed, LE
Vunjak-Novakovic, G
机构
[1] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA
[2] Univ Basel, Dept Surg, CH-4031 Basel, Switzerland
[3] Univ Basel, Dept Res, CH-4031 Basel, Switzerland
[4] MIT, Dept Chem Engn, Cambridge, MA 02139 USA
基金
美国国家航空航天局;
关键词
tissue engineering; polyglycolic acid; poly-lactic-co-glycolic acid; cartilage; bone; osteochondral repair;
D O I
10.1016/S0142-9612(00)00127-7
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Osteochondral repair involves the regeneration of articular cartilage and underlying bone, and the development of a well-defined tissue-to-tissue interface. We investigated tissue engineering of three-dimensional cartilage/bone composites based on biodegradable polymer scaffolds, chondrogenic and osteogenic cells. Cartilage constructs were created by cultivating primary bovine calf articular chondrocytes on polyglycolic acid meshes; bone-like constructs were created by cultivating expanded bovine calf periosteal cells on foams made of a blend of poly-lactic-co-glycolic acid and polyethylene glycol. Pairs of constructs were sutured together after 1 or 4 weeks of isolated culture, and the resulting composites were cultured for an additional 4 weeks. All composites were structurally stable and consisted of well-defined cartilaginous and bone-like tissues. The fraction of glycosaminoglycan in the cartilaginous regions increased with time, both in isolated and composite cultures. In contrast, the mineralization in bone-like regions increased during isolated culture, but remained approximately constant during the subsequent composite culture. The integration at the cartilage/bone interface was generally better for composites consisting of immature (1-week) than mature (4-week) constructs. This study demonstrates that osteochondral tissue composites for potential use in osteochondral repair can be engineered in vitro by culturing mammalian chondrocytes and periosteal cells on appropriate polymer scaffolds. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2599 / 2606
页数:8
相关论文
共 36 条
[1]  
BERT J M, 1989, Arthroscopy, V5, P25, DOI 10.1016/0749-8063(89)90086-8
[2]   Expression of a stable articular cartilage phenotype without evidence of hypertrophy by adult human articular chondrocytes in vitro [J].
Binette, F ;
McQuaid, DP ;
Haudenschild, DR ;
Yaeger, PC ;
McPherson, JM ;
Tubo, R .
JOURNAL OF ORTHOPAEDIC RESEARCH, 1998, 16 (02) :207-216
[3]   TREATMENT OF DEEP CARTILAGE DEFECTS IN THE KNEE WITH AUTOLOGOUS CHONDROCYTE TRANSPLANTATION [J].
BRITTBERG, M ;
LINDAHL, A ;
NILSSON, A ;
OHLSSON, C ;
ISAKSSON, O ;
PETERSON, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (14) :889-895
[4]  
Caplan AI, 1997, CLIN ORTHOP RELAT R, P254
[5]  
Chen F S, 1999, Am J Orthop (Belle Mead NJ), V28, P88
[6]  
Clark G, 1981, STAINING PROCEDURES, P171
[7]   BIODEGRADABLE POLYMER SCAFFOLDS FOR TISSUE ENGINEERING [J].
FREED, LE ;
VUNJAKNOVAKOVIC, G ;
BIRON, RJ ;
EAGLES, DB ;
LESNOY, DC ;
BARLOW, SK ;
LANGER, R .
BIO-TECHNOLOGY, 1994, 12 (07) :689-693
[8]   Chondrogenesis in a cell-polymer-bioreactor system [J].
Freed, LE ;
Hollander, AP ;
Martin, I ;
Barry, JR ;
Langer, R ;
Vunjak-Novakovic, G .
EXPERIMENTAL CELL RESEARCH, 1998, 240 (01) :58-65
[9]   Tissue engineering of cartilage in space [J].
Freed, LE ;
Langer, R ;
Martin, I ;
Pellis, NR ;
VunjakNovakovic, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (25) :13885-13890
[10]  
FREED LE, 2000, BIOMEDICAL ENG HDB, P1